← Back to Clinical Trials
Recruiting NCT05179109

NCT05179109 Robotic Versus Laparoscopic Surgery for Deep Endometriosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05179109
Status Recruiting
Phase —
Sponsor University of Oulu
Condition Endometriosis
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2022-10-03
Primary Completion 2025-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Minimally invasive surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2022-10-03 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.

Eligibility Criteria

Inclusion Criteria: * ASA (American Society of Anesthesiologists physical status classification) 1-3 * Diagnosed deep endometriosis (MRI) * Patient has symptoms * Operative treatment is indicated * Patient is able to give informed consent Exclusion Criteria: * ASA \> 3 * Recurring rectosigmoid endometriosis

Contact & Investigator

Central Contact

Anna M Terho, MD

✉ anna.terho@fimnet.fi

📞 +35883153603

Principal Investigator

Sari Koivurova, MD, PhD

PRINCIPAL INVESTIGATOR

Oulu University Hospital, Department of Obstetrics and Gynecology

Frequently Asked Questions

Who can join the NCT05179109 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05179109 currently recruiting?

Yes, NCT05179109 is actively recruiting participants. Contact the research team at anna.terho@fimnet.fi for enrollment information.

Where is the NCT05179109 trial being conducted?

This trial is being conducted at Oulu, Finland.

Who is sponsoring the NCT05179109 clinical trial?

NCT05179109 is sponsored by University of Oulu. The principal investigator is Sari Koivurova, MD, PhD at Oulu University Hospital, Department of Obstetrics and Gynecology. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology